<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Mylan Pharmaceuticals Inc. | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Mylan Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="19" />
	<language>en-us</language>
	<item>
		<title><![CDATA[More generics receive clearance for marketing by the FDA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_21_30/ai_n31196470]]></link>
		<description><![CDATA[WASHINGTON -- The Actavis Group has received Food and Drug Administration approval to market bupropion hydrochloride extended-release tablets, 150 mg. The company also markets a 300-mg version of the product, indicated for the treatment of major depressive disorder.  Annual sales of brand and generic versions of the drug in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 08 Dec 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sandoz.html"><![CDATA[Sandoz]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Requip now has generic competitors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_11_30/ai_n29447157]]></link>
		<description><![CDATA[WASHINGTON -- The Food and Drug Administration last month approved the first generic versions of Requip GlaxoSmithKline PLC for treating moderate to severe restless leg syndrome. Ropinirole hydrochloride tablets were cleared in 0.25-, 0.5-, 1-, 2-, 3- and 4-mg dosages.  "This generic drug approval is an example of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_29/ai_n29379587]]></link>
		<description><![CDATA[1500 Corporate Dr.  Canonsburg, Pa. 15317  Key contact:  HARRY KORMAN, President  Phone: (724)-514-1800  Fax: 724-514-1870  www.mylan.com  CANONSBURG, Pa. -- Mylan Laboratories Inc. is one of the world's leading generics and speciality pharmaceutical companies. As one of the generics industry's pioneers, Mylan has remained...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Daiichi Wins Lawsuit Against Mylan Pharmaceuticals Regarding Patents]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20051227/ai_n24408854]]></link>
		<description><![CDATA[Tokyo, Dec 27, 2005 - JCN - Daiichi Sankyo has announced that its wholly owned subsidiary Daiichi Pharmaceutical has won the lawsuit against Mylan Pharmaceuticals.    Specifically, the US Court of Appeals for the Federal Circuit has affirmed the validity of US patent (No. 5,053,407) on levofloxacin, a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Dec 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Generic drug companies fight threat from big brands.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200408/ai_n22221037]]></link>
		<description><![CDATA[By Lewis Krauskopf, The Record, Hackensack, N.J. Knight  Ridder/Tribune Business News    Aug. 22--A divisive practice is roiling the generic pharmaceutical   industry, with some companies saying consumers are losing out.    The practice involves "authorized generics," which are  basically brand  drugs...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 22 Aug 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_25/ai_n29056937]]></link>
		<description><![CDATA[781 Chestnut Ridge Rd. Morgantown, W. Va. 26505-4310  Phone: (304) 599-2595 Fax: (304) 598-3232  Web site: mylan.com; mylanpharms.com  Key contact: Jason Harper, associate director of marketing  MORGANTOWN, W.Va. -- Mylan Pharmaceuticals Inc.'s parent company Mylan Laboratories Inc. announced financial results for the first quarter ended June...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 29 Sep 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Omeprazole. (Pharma in Brief).(Mylan Pharmaceuticals launches delayed release capsules)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200308/ai_n13359853]]></link>
		<description><![CDATA[OMEPRAZOLE Mylan Laboratories Inc., through its wholly owned  subsidiary Mylan Pharmaceuticals Inc., has launched 10 mg and 20 mg  omeprazole delayed release capsules. The drug is the generic version of  AstraZeneca PLC's Prilosec.   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 11 Aug 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Getting poised for a steeper growth curve]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3374/is_2_25/ai_97998966]]></link>
		<description><![CDATA[New YORK -- The winds of change have begun to fill the generic drug industry's sails. Driven by expiring patents on big-selling blockbuster drugs and the frantic search for lower-cost prescription alternatives by health plan payers, generic utilization rates have grown roughly 6 percent by volume over the past two...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Feb 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/alpharma.html"><![CDATA[Alpharma]]></category>
		<category domain="http://resources.bnet.com/topic/eon+labs.html"><![CDATA[Eon Labs]]></category>
		<category domain="http://resources.bnet.com/topic/ethex+corp..html"><![CDATA[Ethex Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy+laboratories+ltd..html"><![CDATA[Ranbaxy Laboratories Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RBXZ F</category>
		<category domain="tickers">RBXZ F</category>
	</item>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_24/ai_n28947825]]></link>
		<description><![CDATA[781 Chestnut Ridge Rd.  Morgantown, W.Va. 26505-4310  Phone: (304) 599-2595  (800) 796-9526  Fax: (304) 598-3232  Web site: mylan.com; mylanpharms.com  MORGANTOWN, W.Va. -- Life at 40 is proving to be a busy time for Mylan Pharmaceuticals Inc.  A year after celebrating the completion of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Sep 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ENTREPRENEUR OF THE YEAR: MILAN PUSKAR, Founder, President &amp; CeO, Mylan Laboratories]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5949/is_200206/ai_n24047721]]></link>
		<description><![CDATA[MORGANTOWN - When Milan Puskar decided to open his own pharmaceutical business back in 1961, he had one idea in mind - to build a company that allows employees to enjoy their work, be proud of what they accomplish, share in the company's success and do things the right way.Not...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 24 Jun 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
